Effects of warm-supplementing kidney yang (WSKY) capsule added on risperidone on cognition in chronic schizophrenic patients: a randomized, double-blind, placebo-controlled, multi-center clinical trial

2008 ◽  
Vol 23 (6) ◽  
pp. 465-470 ◽  
Author(s):  
Zhen-hua Chen ◽  
Gao-hua Wang ◽  
Xiao-ping Wang ◽  
Ren-yun Chen ◽  
Hui-lin Wang ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Chronic Schizophrenic ◽  
Schizophrenic Patients

Propranolol in Schizophrenia: A Double Blind, Placebo Controlled Trial of Propranolol as an Adjunct to Neuroleptic Medication

1983 ◽  
Vol 143 (2) ◽  
pp. 151-155 ◽  
Author(s):  
C. R. Pugh ◽  
J. Steinert ◽  
R. G. Priest
Keyword(s):  
Beneficial Effect ◽  
Recent Work ◽  
Controlled Trial ◽  
Pharmacokinetic Interaction ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Neuroleptic Medication ◽  
Chronic Schizophrenic ◽  
Schizophrenic Patients

SummaryA double blind, placebo controlled trial was carried out to examine the contribution of propranolol as an adjunct to neuroleptic medication in the treatment of chronic schizophrenic patients whose florid symptoms had not remitted with neuroleptic medication alone. Propranolol was shown to have a more beneficial effect than placebo, but the results were much less dramatic than those which have been described in previous studies. Recent work has shown that there may be a pharmacokinetic interaction between propranolol and neuroleptics, and this should be considered as one possible explanation of our findings.

A Clinical Trial of the Efficacy and Acceptability of d-Fenfluramine in the Treatment of Neuroleptic-induced Obesity

1988 ◽  
Vol 153 (2) ◽  
pp. 208-213 ◽  
Author(s):  
E. Goodall ◽  
Christine Oxtoby ◽  
Ray Richards ◽  
Gill Watkinson ◽  
David Brown ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Weight Loss ◽  
Side Effects ◽  
Mental State ◽  
Controlled Trial ◽  
Dietary Advice ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Schizophrenic Patients ◽  
Depot Neuroleptic

Twenty-nine overweight schizophrenic patients maintained on depot neuroleptic injections who wished to lose weight took part in a double-blind, placebo-controlled trial of 30 mg d-fenfluramine. All subjects received dietary advice. Sixteen patients completed the 12-week trial. Rate of weight loss was significantly greater in those taking d-fenfluramine. Side-effects were reported, but no deterioration in mental state was noted.

scholarly journals Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind Placebo

BMJ ◽  
1973 ◽  
Vol 1 (5854) ◽  
pp. 633-637 ◽  
Author(s):  
S. R. Hirsch ◽  
R. Gaind ◽  
P. D. Rohde ◽  
B. C. Stevens ◽  
J. K. Wing
Keyword(s):  
Double Blind ◽  
Double Blind Placebo ◽  
Chronic Schizophrenic ◽  
Schizophrenic Patients ◽  
Long Acting

Double blind placebo controlled clinical trial of homoeopathic medicines in HIV infection

1998 ◽  
Vol 87 (2) ◽  
pp. 86-88
Author(s):  
D P Rastogi ◽  
V P Singh ◽  
Vikram Singh ◽  
S K Dey ◽  
K Rao
Keyword(s):  
Clinical Trial ◽  
Hiv Infection ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document